| |
 |
Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)]
|
| |
|
pp.817-817 (1) Author: Gregoire Pierre Prevost |
| |
|
|
| |
 |
Cell Cycle Control by the CDC25 Phosphatases
|
| |
|
pp.818-824 (7) Authors: Bernadette Aressy, Bernard Ducommun |
| |
|
|
| |
 |
CDC25A: A Rebel Within the CDC25 Phosphatases Family?
|
| |
|
pp.825-831 (7) Authors: Anne Fernandez-Vidal, Anne Mazars, Stephane Manenti |
| |
|
|
| |
 |
In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
|
| |
|
pp.832-836 (5) Authors: Hiroaki Kiyokawa, Dipankar Ray |
| |
|
|
| |
 |
Is Cdc25 a Druggable Target?
|
| |
|
pp.837-842 (6) Authors: John S. Lazo, Peter Wipf |
| |
|
|
| |
 |
Cdc25B Phosphatase Inhibitors in Cancer Therapy: Latest Developments, Trends and Medicinal Chemistry Perspective
|
| |
|
pp.843-856 (14) Authors: Antonio Lavecchia, Antonio Coluccia, Carmen Di Giovanni, Ettore Novellino |
| |
|
|
| |
 |
CDC25 Inhibitors as Anticancer Agents Are Moving Forward
|
| |
|
pp.857-862 (6) Authors: M.-C. Brezak, P. G. Kasprzyk, M.-O. Galcera, O. Lavergne, G. P. Prevost |
| |
|
|
| |
 |
Cdc25A Protein Phosphatase: A Therapeutic Target for Liver Cancer Therapies
|
| |
|
pp.863-871 (9) Authors: Z. Wang, S. Kar, B. I. Carr |
| |
|
|
| |
 |
Proliferation of Breast Cancer Cells: Regulation, Mediators, Targets for Therapy
|
| |
|
pp.872-885 (14) Authors: J. Mester, G. Redeuilh |
| |
|
|
| |
 |
Marine Metabolites Overcoming or Circumventing Multidrug Resistance Mediated by ATP-Dependent Transporters: A New Hope for Patient with Tumors Resistant to Conventional Chemotherapy
|
| |
|
pp.886-903 (18) Authors: Chantal Barthomeuf, Marie-Lise Bourguet-Kondracki, Jean-Michel Kornprobst |
| |
|
|
| |
 |
Chemical and Clinical Development of Darinaparsin, a Novel Organic Arsenic Derivative
|
| |
|
pp.904-909 (6) Authors: Alfonso Quintas-Cardama, Srdan Verstovsek, Emil Freireich, Hagop Kantarjian, Yi Wen Chen, Ralph Zingaro |
| |
|
|
| |
 |
Analogues of Marine Pyrroloiminoquinone Alkaloids: Synthesis and Antitumor Properties
|
| |
|
pp.910-916 (7) Author: Evelyne Delfourne |
| |
|
|
| |
 |
Autotaxin Inhibition: Challenges and Progress Toward Novel Anti-Cancer Agents
|
| |
|
pp.917-923 (7) Authors: Abby L. Parrill, Daniel L. Baker |
| |
|
|